These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32551008)

  • 1. Development of Selective Steroid Inhibitors for the Glucose-6-phosphate Dehydrogenase from
    Fredo Naciuk F; do Nascimento Faria J; Gonçalves Eufrásio A; Torres Cordeiro A; Bruder M
    ACS Med Chem Lett; 2020 Jun; 11(6):1250-1256. PubMed ID: 32551008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding Mode and Selectivity of Steroids towards Glucose-6-phosphate Dehydrogenase from the Pathogen Trypanosoma cruzi.
    Ortiz C; Moraca F; Medeiros A; Botta M; Hamilton N; Comini MA
    Molecules; 2016 Mar; 21(3):368. PubMed ID: 26999093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose 6-Phosphate Dehydrogenase from Trypanosomes: Selectivity for Steroids and Chemical Validation in Bloodstream
    Ortíz C; Moraca F; Laverriere M; Jordan A; Hamilton N; Comini MA
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33445584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period.
    Duschak VG
    Recent Pat Antiinfect Drug Discov; 2016; 11(2):74-173. PubMed ID: 27784230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of new uncompetitive inhibitors of glucose-6-phosphate dehydrogenase.
    Mercaldi GF; Ranzani AT; Cordeiro AT
    J Biomol Screen; 2014 Dec; 19(10):1362-71. PubMed ID: 25121555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 16-bromoepiandrosterone, an activator of the mammalian immune system, inhibits glucose 6-phosphate dehydrogenase from Trypanosoma cruzi and is toxic to these parasites grown in culture.
    Cordeiro AT; Thiemann OH
    Bioorg Med Chem; 2010 Jul; 18(13):4762-8. PubMed ID: 20570159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
    Vallejo M; Reyes PP; Martinez Garcia M; Gonzalez Garay AG
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004102. PubMed ID: 33305846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated high-content assay for compounds selectively toxic to Trypanosoma cruzi in a myoblastic cell line.
    Alonso-Padilla J; Cotillo I; Presa JL; Cantizani J; Peña I; Bardera AI; Martín JJ; Rodriguez A
    PLoS Negl Trop Dis; 2015 Jan; 9(1):e0003493. PubMed ID: 25615687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A flow cytometer-based method to simultaneously assess activity and selectivity of compounds against the intracellular forms of Trypanosoma cruzi.
    Miranda CG; Solana ME; Curto MLA; Lammel EM; Schijman AG; Alba Soto CD
    Acta Trop; 2015 Dec; 152():8-16. PubMed ID: 26272680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target-based Screening of the Chagas Box: Setting Up Enzymatic Assays to Discover Specific Inhibitors Across Bioactive Compounds.
    Salas-Sarduy E; Niemirowicz GT; José Cazzulo J; Alvarez VE
    Curr Med Chem; 2019; 26(36):6672-6686. PubMed ID: 31284853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanocidal effect of the benzyl ester of N-propyl oxamate: a bi-potential prodrug for the treatment of experimental Chagas disease.
    Wong-Baeza C; Nogueda-Torres B; Serna M; Meza-Toledo S; Baeza I; Wong C
    BMC Pharmacol Toxicol; 2015 Apr; 16():10. PubMed ID: 25896924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-6-phosphate dehydrogenase is the target for the trypanocidal action of human steroids.
    Gupta S; Cordeiro AT; Michels PA
    Mol Biochem Parasitol; 2011 Apr; 176(2):112-5. PubMed ID: 21185333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Pyrazolo[3,4-e][1,4]thiazepin based CYP51 inhibitors as potential Chagas disease therapeutic alternative: In vitro and in vivo evaluation, binding mode prediction and SAR exploration.
    Ferreira de Almeida Fiuza L; Peres RB; Simões-Silva MR; da Silva PB; Batista DDGJ; da Silva CF; Nefertiti Silva da Gama A; Krishna Reddy TR; Soeiro MNC
    Eur J Med Chem; 2018 Apr; 149():257-268. PubMed ID: 29501946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a series of alpha-pyrone derivatives against Leishmania (L.) infantum and Trypanosoma cruzi.
    Tempone AG; Ferreira DD; Lima ML; Costa Silva TA; Borborema SET; Reimão JQ; Galuppo MK; Guerra JM; Russell AJ; Wynne GM; Lai RYL; Cadelis MM; Copp BR
    Eur J Med Chem; 2017 Oct; 139():947-960. PubMed ID: 28881289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-
    Menozzi CAC; França RRF; Luccas PH; Baptista MDS; Fernandes TVA; Hoelz LVB; Sales Junior PA; Murta SMF; Romanha A; Galvão BVD; Macedo MO; Goldstein ADC; Araujo-Lima CF; Felzenszwalb I; Nonato MC; Castelo-Branco FS; Boechat N
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodrugs as new therapies against Chagas disease: in vivo synergy between Trypanosoma cruzi proline racemase inhibitors and benznidazole.
    de Melo GD; Coatnoan N; Gouault N; Cupif JF; Renault J; Cosson A; Uriac P; Blondel A; Minoprio P
    J Glob Antimicrob Resist; 2022 Mar; 28():84-89. PubMed ID: 34929377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole.
    Luna KP; Hernández IP; Rueda CM; Zorro MM; Croft SL; Escobar P
    Biomedica; 2009 Sep; 29(3):448-55. PubMed ID: 20436996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of new 1,2,3-triazoles derived from eugenol and analogues with in vitro and in vivo activity against Trypanosoma cruzi.
    Reis RCFM; Dos Santos EG; Benedetti MD; Reis ACC; Brandão GC; Silva GND; Diniz LA; Ferreira RS; Caldas IS; Braga SFP; Souza TB
    Eur J Med Chem; 2023 Oct; 258():115622. PubMed ID: 37441850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi.
    Rodrigues JH; Ueda-Nakamura T; Corrêa AG; Sangi DP; Nakamura CV
    PLoS One; 2014; 9(1):e85706. PubMed ID: 24465654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.